Explorer
Know how is ZyCoV-D vaccine different from other
The phase II study of the vaccine ZyCoV-D had been conducted in over 1,000 healthy adult volunteers as part of the adaptive phase I/II dose escalation, multi-centric, randomised, double-blind placebo controlled study. The vaccine was found to be safe and immunogenic. Watch video to know more.
India
Breaking: NEET Paper Leak Case Hearing Delayed as CBI Lawyer Fails to Appear in Fast Track Court
Breaking: Viral Girl Riya Ahir Reports Online Threats, Files Complaint With Cyber Crime Police
Political War Over Student Protest: Opposition Targets Government After Bihar AK-47 Firing Row
Student Tragedy: Maharashtra NEET Aspirant Dies by Suicide, Re-Exam Scores Mentioned in Note
Political Update: Dharmendra Pradhan Receives Grand Welcome From BJP MPs After Stepping Down as Minister
View More
Trending News




















